Clinical Trial Update: Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pharmacokinetics, efficacy, safety, and immunogenicity of a recombinant factor VIII in patients with severe Hemophilia A has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• recombinant Factor VIII (Factor VIII, recombinant)

Snippet

Sponsor: Octapharma | Conditions: Hemophilia A | Phase 2 | Status: COMPLETED | Results posted: 2014-01-17